Industry Veteran Launches New CRO, Dr. Vince Clinical Research, and Begins Headquarters Construction

OVERLAND PARK, KS., October 26, 2021 – Dr. Brad Vince announced he has founded a new clinical research organization and is building a cutting-edge headquarters and research complex in Kansas City. The organization, Dr. Vince Clinical Research, P.A., will formally commence clinical trials in summer 2022.

“Our goal is to create a world-class clinical pharmacology unit. We are constructing a green-certified facility from the ground up, investing in environmental performance and sustainability, technology and infrastructure so we can provide smarter, faster data® to our biopharmaceutical clients. This innovative approach will fundamentally change the way Phase I trials are conducted,” stated CEO and Medical Director Brad Vince, D.O.

Dr. Vince is building a team of hand-selected key leaders to join him in accomplishing his vision. To attract and retain top research talent, the company is offering one of the most robust and comprehensive benefits packages in the region. The company also features a collaborative work environment and unrivaled amenities, designed to inspire dedicated employees who take pride in their work and provide unparalleled service for clients.

With more than 20 years experience in the clinical research industry, Dr. Vince has served as an Investigator in over 700 clinical trials and authored numerous scientific publications. He also has deep industry experience in government studies, including acting as Principal Investigator for various FDA and NIH trials. Dr. Vince is well-known in the industry for his passion, energy and 24/7/365 availability. 

About Dr. Vince Clinical Research
Dr. Vince Clinical Research (DVCR) is a full-service contract research organization (CRO) specializing in early phase trials in both healthy normal volunteers and patient populations across a wide range of trial designs and multiple therapeutic areas such as neuroscience, psychiatry, substance abuse, pain, cardiometabolic disorders, infectious diseases and others. CRO services include project management, data management, biostatistics, monitoring, PK/PD analysis, medical writing as well as site feasibility and management for multi-center trials. Additionally, DVCR operates one of the most innovative and technologically advanced clinical pharmacology units in the world with over 90 beds for overnight confinement, a cGMP compliant pharmacy as well as luxurious amenities to support diverse study participant recruitment and retention. By leveraging technology and one of the country’s most experienced leadership teams in early clinical development, DVCR provides Smarter Faster Data® to their biopharmaceutical clients.


For more information, contact:
Zach Bader
Vice President, Business Development
Dr. Vince Clinical Research